Caveat against the use of feiba in combination with recombinant factor viia.
von Heymann
Christian
C
Ziemer
Sabine
S
Kox
Wolfgang J
WJ
Spies
Claudia
C
D001779:Blood Coagulation Factors / Q000008:administration & dosage / Q000009:adverse effects*; D006348:Cardiac Surgical Procedures / Q000009:adverse effects*; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D015199:Extracorporeal Membrane Oxygenation; D005167:Factor VII / Q000008:administration & dosage / Q000009:adverse effects*; D017809:Fatal Outcome; D006470:Hemorrhage / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D012720:Severity of Illness Index; D013927:Thrombosis / Q000139:chemically induced*
D001779:Blood Coagulation Factors; D005167:Factor VII; C065655:anti-inhibitor coagulant complex